Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,100.00
Bid: 1,094.00
Ask: 1,100.00
Change: -16.00 (-1.43%)
Spread: 6.00 (0.548%)
Open: 1,154.00
High: 1,154.00
Low: 1,098.00
Prev. Close: 1,116.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Acquisitions

29 Jun 2010 07:00

RNS Number : 3866O
CVS Group plc
29 June 2010
 



 

Trading update and Acquisitions

 

The Board announced on 19 May 2010 that it expected results for the year to be below market expectations. Trading conditions have remained tough throughout the rest of the group's financial year which will end on 30 June 2010. Having reviewed flash numbers the Board now believes that turnover for the year will be in the region of £85m (net of inter company sales of £2m). This is in the region of £1m below Directors' expectations for the final quarter.

 

Whilst the Board is disappointed to report lower than anticipated turnover, the performance will still reflect modest like-for-like growth for the year as a whole (after adjusting for the weather affected months of December 2009 and January 2010) despite the challenging environment.

 

The Board is pleased to report that the Group has delivered a better than expected level of acquisition activity in the year, which is expected to generate annualised turnover in the region of £21 million, compared to the £12m expected at the start of the financial year. However, as previously highlighted, the bulk of these have been acquired in the latter part of the financial year, which means that they will only deliver £6 million of sales in this current year. The total number of surgeries acquired in the year amounted to 41 together with one laboratory.

 

Three new acquisitions have been completed in June funded by internally generated cash, comprising five surgeries located in the vicinity of Mansfield, Horsham and Burgess Hill respectively. The combined annual turnover for the five surgeries is circa £2.7 million.

 

Senior Management Appointment

The Board is also pleased to confirm the recent appointment of Steve Scully as the Director of Practice Operations for the Group. Steve will sit on the Executive Committee and brings with him a broad range of experience and a proven track record in driving growth within large multi site operations.

 

 

For further enquiries please contact:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

 

 

Brewin Dolphin

Richard Jones/Matt Davis

Paul Mason

0845 059 6740

 

 

Buchanan Communications

Richard Oldworth

Ben Romney

020 7466 5000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKFDPKBKBNAB
Date   Source Headline
22nd Jan 20205:08 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSHolding(s) in Company
10th Jan 20203:46 pmRNSLong Term Incentive Plan Awards - replacement
10th Jan 20209:27 amRNSHolding(s) in Company
8th Jan 20203:57 pmRNSLong Term Incentive Plan Awards
7th Jan 20204:58 pmRNSHolding(s) in Company
6th Jan 202012:02 pmRNSPrice Monitoring Extension
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20199:29 amRNSHolding(s) in Company
20th Dec 20193:15 pmRNSLong Term Incentive Plan Awards
12th Dec 20199:39 amRNSHolding(s) in Company
2nd Dec 201912:17 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSBoard Appointments
29th Nov 20197:00 amRNSResult of AGM
28th Nov 20197:00 amRNSAnnual General Meeting Statement
21st Nov 201910:15 amRNSHolding(s) in Company
20th Nov 20197:00 amRNSHolding(s) in Company
11th Nov 20199:19 amRNSHolding(s) in Company
8th Nov 201912:13 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSChange of CEO and Other Directorate Changes
5th Nov 20195:53 pmRNSHolding(s) in Company
5th Nov 20197:00 amRNSPosting of AR, Notice of AGM & Dividend Timetable
1st Nov 20195:38 pmRNSHolding(s) in Company
31st Oct 20194:33 pmRNSExercise of Options and Total Voting Rights
18th Oct 20199:16 amRNSHolding(s) in Company
9th Oct 201911:16 amRNSHolding(s) in Company
8th Oct 20196:12 pmRNSDirector/PDMR and PCA Shareholding
2nd Oct 201910:06 amRNSHolding(s) in Company
30th Sep 20194:14 pmRNSExercise of Options and Total Voting Rights
27th Sep 20197:00 amRNSPreliminary Results for year ended 30 June 2019
25th Sep 201912:42 pmRNSHolding(s) in Company
24th Sep 201910:34 amRNSHolding(s) in Company
12th Sep 20194:33 pmRNSHolding(s) in Company
12th Sep 20192:50 pmRNSHolding(s) in Company
12th Sep 20199:48 amRNSHolding(s) in Company
11th Sep 20193:42 pmRNSHolding(s) in Company
10th Sep 20193:46 pmRNSHolding(s) in Company
4th Sep 20192:15 pmRNSHolding(s) in Company
2nd Sep 20195:37 pmRNSHolding(s) in Company
2nd Sep 20199:22 amRNSHolding(s) in Company
30th Aug 20192:51 pmRNSExercise of Options and Total Voting Rights
29th Aug 20195:38 pmRNSHolding(s) in Company
22nd Aug 201910:23 amRNSHolding(s) in Company
12th Aug 20194:53 pmRNSHolding(s) in Company
12th Aug 20199:21 amRNSHolding(s) in Company
8th Aug 201911:34 amRNSHolding(s) in Company
5th Aug 20199:12 amRNSHolding(s) in Company
1st Aug 20197:00 amRNSExercise of Options and Total Voting Rights
26th Jul 20197:00 amRNSTrading Update
16th Jul 20199:55 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.